LION BIOTECHNOLOGIES INC - COM (LBIO)

CUSIP: 53619R102

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
36,457,791
Share change
+1,136,123
Total reported value
$185,175,000
Put/Call ratio
7.5%
Price per share
$5.08
Number of holders
77
Value change
+$4,598,545
Number of buys
40
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 53619R102?
CUSIP 53619R102 identifies LBIO - LION BIOTECHNOLOGIES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q1 2016

As of 31 Mar 2016, LION BIOTECHNOLOGIES INC - COM (LBIO) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,457,791 shares. The largest 10 holders included FMR LLC, venBio Select Advisor LLC, PERCEPTIVE ADVISORS LLC, RS INVESTMENT MANAGEMENT CO LLC, ACUTA CAPITAL PARTNERS, LLC, FRANKLIN RESOURCES INC, Broadfin Capital, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, and QVT Financial LP. This page lists 77 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.